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Reactive oxygen species (ROS), along with reactive nitrogen species (RNS), may
play an important role in the pathogenesis and progressing of many diseases. The cu-
mulative production of ROS/RNS through either endogenous or exogenous insults is
termed oxidative stress and is responsible for or contributes to many pathological condi-
tions (1). For example, inflammatory tissue injuries are mediated by reactive oxygen me-
tabolites from phagocytic leukocytes (e.g., neutrophils, monocytes, macrophages, and
eosinophils) that invade the tissue. These reactive radicals and oxidants may injure cells
and tissue directly via oxidative degradation of essential cellular components or indi-
rectly by altering the protease/antiprotease balance that normally exists within the in-
testinal tissue (2).
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In the present study, seven hydroxamic acid derivatives
of nonsteroidal anti-inflammatory drugs (NSAIDs) (ibu-
profen, fenoprofen, ketoprofen, indomethacin and diclo-
fenac) were found to possess significant antioxidant, ra-
dical scavenging and metal chelating activities. The most
active antioxidant and radical scavenger was N-methyl-
hydroxamic acid of diclofenac (ANT = 88.0 % and EC50 =
60.1 mg mL–1). The activity of the standard substance,
butylated hydroxyanisole, in the two assays was ANT =
86.9 % and EC50 = 18.8 mg mL–1, respectively. Ibuproxam
was the strongest iron chelator among investigated hy-
droxamic acids (EC50 = 255.6 mg mL–1), yet significantly
weaker than the standard substance, EDTA (EC50 = 29.1
mg mL–1). It seems that different mechanism is involved
in metal chelating activity than in antioxidant and radi-
cal scavenging activity. Antioxidant and radical scaveng-
ing activities may be connected with conjugation of the
nitrogen lone electron pair with the carbonyl group. On
the other hand, more hydrophilic substances tend to be
better iron chelators.
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Previous research has shown that derivatization of well known NSAIDs to the cor-
responding hydroxamic acids yields substances with anti-inflammatory activity (3). Two
of them, ibuproxam and oxamethacin, hydroxamic acid derivatives of ibuprofen and in-
domethacin, are efficient and internationally registered drugs (4). Since antioxidant ac-
tivity of substances may have an important role in their anti-inflammatory and antipro-
liferative activities, the aim of this work was to determine the antioxidant properties of




Melting points were determined on a Stuart Melting Point Apparatus SMP3 (Stuart
Barworld Scientific, UK) and were uncorrected. IR spectra were recorded on a FTIR Per-
kin Elmer Paragon 500 spectrometer (Perkin Elmer, UK). For absorbance measurements,
a Lambda 25 (Perkin Elmer, UK) spectrophotometer was used. NSAID hydroxamic acids,
namely N-hydroxy-2-(4-isobutyl-phenyl)propanamide (ibuproxam, 1), N-hydroxy-2-(3-
-phenoxy-phenyl)propanamide (2), N-hydroxy-2-(3-benzyl-phenyl)propanamide (3), N-hy-
droxy-2-[3-(hydroxy-phenyl-methyl)-phenyl]propanamide (4), 2-[1-(4-chloro-benzoyl)-
-5-methoxy-2-methyl-1H-indol-3-yl-]-N-hydroxy-acetamide (oxamethacin, 5), 2-[2-(2,6-di-
chloro-phenylamino)-phenyl]-N-hydroxy-acetamide (6) and 2-[2-(2,6-dichloro-phenylami-
no)-phenyl]-N-hydroxy-N-methyl-acetamide (7) (Fig. 1) were prepared following a pre-
viously published procedure (5, 6). All analytical and spectral data were in agreement
with the previously published results. Butylated hydroxyanisol (BHA), 1,1-diphenyl-2-
-picrylhydrazyl (DPPH), b-carotene, linoleic acid and ferrozine were purchased from
Sigma-Aldrich (USA). Other chemicals and solvents used were of analytical grade.
Determination of the antioxidant activity using the b-carotene-linoleate assay
The antioxidant activity of hydroxamic acids was evaluated using a b-carotene-lino-
leic acid model system (7). To 1 mL of b-carotene solution in chloroform (0.2 mg mL–1),
20 mg of linoleic acid and 200 mg of Tween 40 were added. After removing chloroform
in a rotary evaporator, 50 mL of aerated distilled water was added under vigorous stirr-
ing. Aliquots (5 mL) of thus obtained emulsion were transferred to a series of tubes con-
taining 2 mg of hydroxamic acid or 0.5 mg of butylated hydroxyanisol (BHA, standard).
The tube to which no antioxidant was added served as a negative control. The tubes
were placed in a water bath at 50 °C for 2 h. Absorbance of each sample was measured
at 470 nm immediately after sample preparation and at 15-minutes intervals until the
end of the experiment. A blank, devoid of b-carotene, was prepared for background sub-
traction. The antioxidant activity (ANT) was expressed as described in the literature (8)
using the average bleaching rates of the negative control and antioxidant (hydroxamic
acid or BHA), respectively. The rates of b-carotene bleaching for hydroxamic acids, BHA
and water, were calculated according to first-order kinetics:
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where t is the time in minutes, A0 is the initial absorbance of the emulsion immediately
after sample preparation (t = 0 min) and At is the absorbance at three time intervals (t =
15, 30 or 45 min). Based on the rates determined at three time intervals, the average rate
of b-carotene degradation was calculated. Furthermore, the antioxidant activity was cal-
culated from the absolute changes in absorbance at t = 60 and 120 min (AA60 and AA120,
respectively) (9). The results were normalized using both controls: negative and positive.
The first should offer no protection against oxidation of b-carotene in emulsion, while
the other should offer maximum protection during the assay. Accordingly, the antioxi-
dant activity of the compounds was expressed as:
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where A0 is the absorbance of the tested compound solution at 0 min, At is the absor-
bance at t = 60 or 120 min, A0
W is the absorbance of the negative control at 0 min, At
W is
the absorbance of the control at t = 60 or 120 min, A0
BHA is the absorbance of BHA solution
at 0 min and At
BHA is the absorbance of BHA solution at t = 60 or 120 min.
Free radical scavenging activity (RSA)
The scavenging effect for DPPH radical was monitored according to the method of
Yen and Chen (10) with minor modification. Briefly, 1.0 mL of hydroxamic acid solution
(g = 50–300 mg mL–1) was added to 1.0 mL of DPPH ethanolic solution (c = 0.16 mmol
L–1). The mixtures were vortexed for 1 min and then left to stand at room temperature in
the dark. After 30 min, absorbance was read at 517 nm. RSA for DPPH free radical was
calculated using Acontrol (absorbance of the control, solution to which no antioxidant was
added) and Asample (absorbance of the hydroxamic acid solution). Bleached DPPH solu-
tion, prepared by adding 1.0 mL of DPPH solution (c = 0.16 mmol L–1) to 1.0 mL BHA
solution (g = 1 mg mL–1), was used as a blank. DPPH radical scavenging activity was cal-
culated as EC50, the concentration that scavenges 50 % of DPPH free radical and thus
has RSA = 50 %. The antioxidant activity of BHA as standard reference was also assayed.
Metal chelating activity (MChA)
The chelating activity on Fe2+ was measured as reported by Decker and Welch (11).
Hydroxamic acids (50–300 mg) were added to 0.1 mL of FeCl2 solution (c = 2 mmol L–1).
Reaction was initiated by the addition of 0.2 mL ferrozine solution (c = 5 mmol L–1). The
mixture was shaken vigorously and left standing at room temperature for 10 min. After
the reaction reached equilibrium, absorbance was determined at 562 nm. MChAwas cal-
culated according to Acontrol (absorbance of the negative control, solution to which no
chelating agent was added) and Asample (absorbance of the hydroxamic acid solution).
Metal chelating activity of hydroxamic acids was calculated as EC50, the concentration
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that chelates 50 % of Fe2+ ions and thus has MChA = 50 %. Ethylenediaminetetraacetic
acid (EDTA) was used as a standard.
Statistical and log P analysis
All analyses were performed in triplicate. The data were recorded as mean ± stan-
dard deviation. One-way analysis of variance was performed by ANOVA procedures us-
ing the GraphPad Prism version 3.00 for Windows (GraphPad Software, USA). Signifi-
cant differences between means were determined by Tukey’s tests. Unless otherwise
specified, p < 0.05 was regarded as statistically significant. Log P values were calculated
at the Virtual Computational Chemistry Laboratory (12).
RESULTS AND DISCUSSION
In the present work, antioxidant, radical scavenging and metal chelating activities
of a series of NSAID hydroxamic acids, 1-7, were investigated (Fig. 1). Furthermore, re-
lations between the antioxidant activity and wavenumber of the hydroxamic acid car-
bonyl band in IR spectra as well as log P were explored. NSAID hydroxamic acids 1, 2
and 5-7, derivatives of ibuprofen, fenoprofen, indomethacin and diclofenac, were syn-
thesized by aminolysis of the corresponding NSAID benzotriazolide with hydroxylamine
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Fig. 1. Hydroxamic acids investigated in this study.
or methylhydroxylamine, following our previously published method (5). Ketoprofen
derivatives 3 and 4 were prepared by catalytic hydrogenation of N-benzyloxy-2-(3-ben-
zoylphenyl)propanamide (6).
Antioxidant activity (ANT) was measured as the percentage of inhibition of lipid
peroxidation in the b-carotene-linoleic acid system. According to the literature data (9),
normalized antioxidant activity at 60- and 120-minutes of incubation (AA60 and AA120)
reflects the antioxidant activity more accurately than the ANT value.
All hydroxamic acids were able to reduce the rate of degradation of b-carotene (Ta-
ble I) according to the pseudofirst order mechanism (R2 > 0.97). In all the assays per-
formed, the investigated hydroxamic acids were significantly more active (p  0.05) than
the corresponding negative control. The strongest antioxidant among them was diclo-
fenac N-methylhydroxamic acid (7) (ANT = 88.0 ± 2.2 %), whose activity did not signifi-
cantly differ from the activity of BHA (ANT = 86.9 ± 2.6 %). The activity of compound 4
was significantly lower than the activity of the other tested substances (57.4 ± 6.1 %).
The RSA of hydroxamic acids 1-7 was tested using the relatively stable free radical
DPPH. This assay is frequently used because it has the advantage of being unaffected by
certain side reactions, such as metal-ion chelation and enzyme inhibition. In its radical
form, DPPH absorbs at 517 nm, but the absorption decreases upon reaction with an anti-
oxidant due to the formation of its non-radical form, DPPH-H. Transition metals (iron,
copper, chromium, cobalt, vanadium, cadmium, nickel) can also be mediators in the for-
mation of free radicals (e.g., Fenton chemistry). Therefore, metal chelating ability can
also significantly contribute to the overall antioxidant activity. The radical scavenging
activity and the metal chelating effects of NSAID hydroxamic acids were concentration
dependent and increased with an increased amount of sample. The activities in both
239
M. Zovko Kon~i} et al.: Antioxidant activity of NSAID hydroxamic acids, Acta Pharm. 59 (2009) 235–242.
Table I. IR carbonyl absorption bands and antioxidant activity of NSAID hydroxamic
acids 1-7 in the b-carotene-linoleic acid systema
Compd. ANT (%)b AA60 (%)c AA120 (%)d n (CO) (cm–1)e log P
1 82.3 ± 4.5 71.3 ± 4.1 68.3 ± 3.2 1631.9 2.77
2 74.5 ± 3.8 70.6 ± 2.0 67.2 ± 0.9 1628.9 2.73
3 76.8 ± 3.2 68.3 ± 1.9 66.1 ± 1.9 1634.5 3.10
4 57.4 ± 6.1 49.9 ± 4.6 41.5 ± 3.0 1645.5 1.95
5 71.5 ± 1.4 65.9 ± 1.4 63.8 ± 1.0 1635.0 3.22
6 70.5 ± 2.1 65.4 ± 1.0 60.0 ± 0.9 1625.1 3.77
7 88.0 ± 2.2 79.6 ± 1.8 76.7 ± 1.2 1614.7 3.53
BHA 86.9 ± 2.6 80.2 ± 1.0 78.5 ± 1.3  
Controlf
 19.8 ± 1.0 21.5 ± 1.3  
a Mean ± SD (n = 3)
b Antioxidant activity
c Normalized antioxidant activity at 60-min of incubation
d Normalized antioxidant activity at 120-min of incubation
e IR spectra in accordance with the published data (5-6)
f Reaction mixture without antioxidant
tests were calculated as the concentrations exhibiting 50 % of activity (Fig. 2). Hence, a
lower EC50 value indicated higher activity.
Hydroxamic acids 1-7 exhibited satisfactory DPPH free radical scavenging activity
and metal chelating effect with ferrous ions. Among the tested NSAID hydroxamic ac-
ids, diclofenac N-methylhydroxamic acid (7) was a significantly better radical scavenger
than the remaining derivatives (EC50 = 60.1 mg mL–1) but still weaker than the standard
substance, BHA (EC50 = 18.8 mg mL–1). Compound 4 displayed the lowest activity (EC50
= 330 mg mL–1). These results fully correlate with the results of the b-carotene-linoleic
acid model system. Since the least active compound has the lowest log P, one can as-
sume that the lipophilicity is important for the antioxidative activity. On the other hand,
the best metal chelating activity was displayed by ibuprofen hydroxamic acid (1) (EC50 =
255.6 mg mL–1). The other compounds showed lower, but comparable activity. The activ-
ity of the positive control, EDTA, was higher than the activity of tested substances (EC50
= 29.1 mg mL–1).
Useful relationship exists between the chemical reactivity of the compounds bearing
carbonyl functionality and their carbonyl stretching frequencies in the IR spectra. More re-
active derivatives absorb at higher wavenumbers than the less reactive ones (13). On the
other hand, the conjugation effect can cause the vibration to shift to a higher wavenum-
ber, because the carbonyl group enters into resonance with the substituents that bear a
lone pair of electrons (14). Thus, the relationship between the reactivity of hydroxamic
acids and their activity in the performed tests might suggest a mechanism by which the
hydroxamic acids react as antioxidants. The wavenumbers of carbonyl stretching absor-
ptions of the investigated hydroxamic acids are listed in Table I. A negative correlation
(R2 = 0.63) was found between the wavenumbers and the activity in the b-carotene-li-
noleate assay. The correlation increases if AA60 and AA120 are considered (R2 = 0.75 and
0.66, respectively). On the other hand, a weak correlation between the wavenumbers of
carbonyl groups and EC50 in radical scavenging activity was observed (R2 = 0.58). Since
the EC50 value and the radical scavenging activity of a compound are inversely related,
it can be concluded that the activity decreases with an increase in frequency of the car-
bonyl group stretching vibration. This might suggest that the resonance and its conse-
quences (e.g., effect on acidity) might influence the antioxidant reactivity of investigated
hydroxamic acids. On the other hand, there was no correlation between chelating activ-
ity EC50 and the wavenumbers of stretching C=O bands of hydroxamic acids. This might
implicate that the mechanism for metal chelating activity differs from the mechanism by
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Fig. 2. Radical scavenging (RSA)
and metal chelating (MChA) activ-
ities of hydroxamic acids 1-7 pre-
sented as mean EC50 values ± SD
(n = 3) and compared to the stan-
dard (st.): BHA for RSA and EDTA
for MChA.
which the acids react in the former two assays. A weak correlation between log P and
EC50 of metal chelating activity was observed, implicating that the lipophilicity of inves-
tigated hydroxamic acids and their chelating abilities are inversely related (R2 = 0.61).
CONCLUSIONS
In the present study, hydroxamic acid derivatives of NSAIDs were found to possess
significant antioxidant, radical scavenging and metal chelating activities, as determined
by the b-carotene-linoleic acid model system, scavenging effect on the DPPH free radical
as well as metal chelation effect in the Fe2+-ferrozin test system. It seems that a different
mechanism is involved in the metal chelating activity than in the antioxidant and radical
scavenging activities. The activity in the latter two tests may be connected with the ex-
tent of conjugation of the nitrogen lone electron pair with the carbonyl group. On the
other hand, more hydrophilic substances were proven to be better iron chelators.
Acronyms. – AA – normalized antioxidant activity; ANT – antioxidant activity; BHA
– butylated hydroxyanisol; DPPH – 1,1-diphenyl-2-picrylhydrazyl; EC50 – concentration
exhibiting 50 % activity; EDTA – ethylenediaminetetraacetic acid; MChA – metal chelat-
ing activity; NSAID – nonsteroidal anti-inflammatory drug; RNS – reactive nitrogen spe-
cies; ROS – reactive oxygen species; RSA – radical scavenging activity.
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S A @ E T A K
Antioksidativno djelovanje NSAID hidroksamskih kiselina
MARIJANA ZOVKO KON^I], ZRINKA RAJI], NEVA PETRI] i BRANKA ZORC
U radu je opisano antioksidativno djelovanje te sposobnost hvatanja slobodnih ra-
dikala i stvaranja kelata sedam hidroksamskih kiselina, derivata nesteroidnih protu-
upalnih lijekova ibuprofena, fenoprofena, ketoprofena, indometacina i diklofenaka. Naj-
ja~e antioksidativno djelovanje i najja~u sposobnost hvatanja slobodnih radikala imala
je N-metilhidroksamska kiselina diklofenaka (ANT = 88,0 % i EC50 = 60,1 mg mL–1).
Vrijednosti za standardnu supstanciju, butilirani hidroksianisol, bile su: ANT = 86,9 % i
EC50 = 18,8 mg mL–1. Derivat ibuprofena bio je najja~i kelator me|u ispitivanim hidro-
ksamskim kiselinama (EC50 = 255,6 mg mL–1), ali zna~ajno slabiji od standardne sup-
stancije, EDTA (EC50 = 29,1 mg mL–1). Pretpostavlja se da su razli~iti mehanizmi uklju-
~eni u keliranje metala i antioksidativno djelovanje, odnosno hvatanje slobodnih radi-
kala. Antioksidativno djelovanje i sposobnost hvatanja slobodnih radikala moglo bi biti
povezano s konjugacijom slobodnog para elektrona na du{iku s karbonilnom skupinom.
S druge strane, hidrofilnije supstancije pokazale su se kao ja~i kelatori iona `eljeza.
Klju~ne rije~i: NSAID, hidroksamska kiselina, antioksidativno djelovanje, vezanje slobodnih radika-
la, sposobnost keliranja metala
Farmaceutsko-biokemijski fakultet, Zagreb
242
M. Zovko Kon~i} et al.: Antioxidant activity of NSAID hydroxamic acids, Acta Pharm. 59 (2009) 235–242.
